This protocol is judged by an institutional review board, an independent team that evaluations any medical trials involving human beings. If a review involves a Timetable I drug, when the board approves the protocol as ethical, the researchers must make an application for an investigational new drug (IND) range within the FDA.Prospects reported mi… Read More